Fresenius SE & Co KGaA/ DE0005785604 /
11/28/2023 5:20:51 PM | Chg. - | Volume | Bid1:02:05 PM | Ask1:02:05 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
28.57EUR | - | 27 Turnover: 771.39 |
-Bid Size: - | -Ask Size: - | 16.18 bill.EUR | 3.20% | 11.77 |
GlobeNewswire
6/11/2021
UPDATE -- Humacyte Expands Strategic Global Partnership with Fresenius Medical Care
GlobeNewswire
2/4/2021
Cove Capital Acquires Fresenius Medical Care Dialysis Facility in New Orleans
GlobeNewswire
11/11/2019
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medica...
GlobeNewswire
11/4/2019
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medica...
GlobeNewswire
10/29/2019
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Fresenius Medica...
GlobeNewswire
10/23/2019
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medic...
GlobeNewswire
7/16/2018
OPKO Partner Vifor Fresenius Receives Marketing Approval for RAYALDEE in Canada
GlobeNewswire
2/21/2018
Global Kidney Dialysis Equipment and Supplies Markets 2016-2024: Fresenius and Baxter Dominate the M...
GlobeNewswire
6/9/2017
KISSEI TO MARKET AVACOPAN IN JAPAN FOR VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA
GlobeNewswire
1/27/2011
Swedish Orphan Biovitrum agrees with Fresenius Biotech to distribute Removab®